Welcome To Our Company
We cross reference to the clients specific illness or ailment. This calculated recommendation is followed up by referring the client to the nearest dispensary or clinic. We will have a dedicated mobile app and a desktop app. Our technology is
proprietary. We have accumulated a huge database of strains, cannabinoids, and medicinal applications. Our management and advisory team is involved in pain management, computers, neuroscience and technology.
Overall , the marijuana industry projections are 31 billion in 2021 from 7.7 billion on January 2018. The medical marijuana industry is projected to grow from 3 billion in 2018 to over 7 billion by 2021. The marijuana industry is projected to create more jobs than the manufacturing industry in 2020.
See what we provide for your health
Doctors WILL now have access to decision making tools which lessens their reliance on experimentation and guesswork, and improves their confidence in consistent and personalized cannabis treatments.
Patients Access To APP
The company expects a BETA launch to happen by the end of 2nd Q of 2018. It should result in thousands of new social media followers and newsletter subscribers, dozens of strategic partnerships and qualified investor leads, and feature stories
Dispensary Access To Data
Our industry specific, cloud-based platform s being developed with robust artificial intelligence and data mining capabilities, positioning the company as the WebMD of the cannabis industry.
We seek to fill that need by creating the industry standard for cannabis-related advice, selection, terminology, and data, all without touching the actual plant – enabling the Company to work in any regulatory environment.
Our product and technology strategy uses pre-existing, fully-vetted and IP-protected technologies – adapted and applied to the cannabis segment to read and the company has access to the various complementary technologies that serve as our building blocks.
Dr. Michael Stern
Michael Stern graduated from medical school in 1973 and since 1983 has been a board-certified urologist and urological surgeon. Dr. Stern served as an adjunct clinical faculty member at Bast-yr University School of Naturopathic Medicine for 11 years (1995 --2006). Dr. Stern operates the Northwest Healthy Options Clinic in Seattle, Washington. Dr. Stern continues advising patients on lifestyle issues and alternative healthy treatments for a wide variety of diseases, including medical cannabis.
Dr. Bindiya Moorjani
Dr. Bindiya Moorjani was a awarded a Ph. D. in biomedical sciences from the Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York University. Dr. Moorjani has authored several scientific studies that have been published in scientific journals. She did major studies on Serotonin. From 1993 through 1999, Dr. Moorjani was a graduate researcher at the Mount Sinai School of Medicine in the doctoral program concentrating on neurobiology.